Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Total Non-Current Liabilities (2018 - 2023)

China Pharma Holdings filings provide 11 years of Total Non-Current Liabilities readings, the most recent being $10.5 million for Q1 2023.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to $10.5 million in Q1 2023 year-over-year; TTM through Mar 2023 was $10.5 million, a N/A change, with the full-year FY2022 number at $11.1 million, down 24.71% from a year prior.
  • Total Non-Current Liabilities hit $10.5 million in Q1 2023 for China Pharma Holdings, down from $11.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $14.7 million in Q4 2021 to a low of $9.6 million in Q3 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $10.5 million (2023), compared with a mean of $11.0 million.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 42.28% in 2021 and later decreased 24.71% in 2022.
  • China Pharma Holdings' Total Non-Current Liabilities stood at $10.6 million in 2019, then decreased by 2.18% to $10.4 million in 2020, then soared by 42.28% to $14.7 million in 2021, then decreased by 24.71% to $11.1 million in 2022, then dropped by 5.3% to $10.5 million in 2023.
  • The last three reported values for Total Non-Current Liabilities were $10.5 million (Q1 2023), $11.1 million (Q4 2022), and $14.7 million (Q4 2021) per Business Quant data.